The global Metabolomics Market was valued at USD 1.15 billion in 2016 and is projected to reach USD 3.91billion by 2025, growing at a CAGR of 14.54% from 2017 to 2025.
Metabolomics is the scientific study of chemical processes involving metabolites. Specifically, metabolomics is the systematic study of the unique chemical fingerprints that specific cellular processes leave behind,
1. Market Drivers
1.1 Availability of Government and Private Funding
1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
1.3 Technological Advancements
1.4 Growing Demand for Personalized Medicine
1.5 Increasing Use of Metabolomics in Toxicology Testing
2. Market Restraints
2.1 Issues Related to Data Examination and Processing
2.2 High Cost of equipment
1. Global MetabolomicsMarket, by Indication:
1.2 Cardiovascular Disorders
1.3 Neurological Disorders
1.4 Inborn Errors of Metabolism
1.5 Other Indications
2. Global MetabolomicsMarket, by Application:
2.1 Biomarker Discovery
2.2 Drug Discovery
2.3 Toxicology Testing
2.5 Functional Genomics
2.6 Personalized Medicine
2.7 Other Applications
3. Global MetabolomicsMarket, by Product and Services:
3.1 Metabolomics Instruments
3.1.1 Separation Tools
18.104.22.168 High-Performance Liquid Chromatography
22.214.171.124 Gas Chromatography
126.96.36.199 Ultra-Performance Liquid Chromatography
188.8.131.52 Capillary Electrophoresis
3.1.2 Detection Tools
184.108.40.206 Mass Spectrometry
220.127.116.11 Nuclear Magnetic Resonance Spectroscopy
18.104.22.168 Surface-Based Mass Analysis
3.2 Metabolomics Bioinformatics tools and services
3.2.1 Bioinformatics Tools & Databases
3.2.2 Bioinformatics Services
4. Global Metabolomics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
The major players in the market are as follows:
1. Thermo Fisher Scientific Inc.
2. Agilent Technologies, Inc.
3. Waters Corporation
4. Danaher Corporation
5. Shimadzu Corporation
6. Biocrates Life Sciences AG
7. Bio-Rad Laboratories, Inc.
8. Bruker Corporation
9. Human Metabolome Technologies, Inc.
10. Leco Corporation
11. Metabolon, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the MetabolomicsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the research methodology of verified market research and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL METABOLOMICSMARKET
1.1 Overview of the Market
1.2 Scope of Report
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL METABOLOMICSMARKETOUTLOOK
4.2 Market Dynamics
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL METABOLOMICS MARKET, BY INDICATION
5.2 Cardiovascular Disorders
5.3 Neurological Disorders
5.4 Inborn Errors of Metabolism
5.5 Other Indications
6 GLOBAL METABOLOMICS MARKET, BY APPLICATION
6.1 Biomarker Discovery
6.2 Drug Discovery
6.3 Toxicology Testing
6.5 Functional Genomics
6.6 Personalized Medicine
6.7 Other Applications
7 GLOBAL METABOLOMICS MARKET, BY PRODUCT AND SERVICES
7.1 Metabolomics Instruments
7.1.1 Separation Tools
22.214.171.124 High-Performance Liquid Chromatography
126.96.36.199 Gas Chromatography
188.8.131.52 Ultra-Performance Liquid Chromatography
184.108.40.206 Capillary Electrophoresis
7.1.2 Detection Tools
220.127.116.11 Mass Spectrometry
18.104.22.168 Nuclear Magnetic Resonance Spectroscopy
22.214.171.124 Surface-Based Mass Analysis
7.1.3 Metabolomics Bioinformatics tools and services
7.1.4 Bioinformatics Tools & Databases
7.1.5 Bioinformatics Services
8 GLOBAL METABOLOMICSMARKET, BY GEOGRAPHY
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 2025
9 GLOBAL METABOLOMICSMARKETCOMPETITIVE LANDSCAPE
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Thermo Fisher Scientific Inc.
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Agilent Technologies, Inc.
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Waters Corporation
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Danaher Corporation
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Shimadzu Corporation
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Biocrates Life Sciences AG
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Bio-Rad Laboratories, Inc.
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Bruker Corporation
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Human Metabolome Technologies, Inc.
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Leco Corporation
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Metabolon, Inc.
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
11.1 Related Reports
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.